Supplemental Cash Flow Information - Summary of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Supplemental cash flow information:
Interest paid	$ 3,672	$ 4,824	$ 7,086
Income taxes paid (refunded), net	5,313	1,819	2
Supplemental disclosure of non-cash financing activities:
Reclassification of contingently redeemable common stock in connection with IPO	0	309,500	0
Issuance of common stock under partner physician group equity agreements upon IPO	0	268,467	0
Offering costs accrued at end of period	0	295	0
Non-cash investment in unconsolidated subsidiaries	190	763	0
Settlement of stock-based liabilities	0	0	1,500
Settlement of loans receivable with services provided	$ 0	$ 0	$ 2,047